431 related articles for article (PubMed ID: 17908955)
1. Hypoxia inducible factor-1 independent pathways in tumor angiogenesis.
Mizukami Y; Kohgo Y; Chung DC
Clin Cancer Res; 2007 Oct; 13(19):5670-4. PubMed ID: 17908955
[TBL] [Abstract][Full Text] [Related]
2. HIFs, angiogenesis, and cancer.
Yang Y; Sun M; Wang L; Jiao B
J Cell Biochem; 2013 May; 114(5):967-74. PubMed ID: 23225225
[TBL] [Abstract][Full Text] [Related]
3. [Hypoxia and angiogenesis].
Simon JM
Bull Cancer; 2007 Jul; 94 Spec No():S160-5. PubMed ID: 17846000
[TBL] [Abstract][Full Text] [Related]
4. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
5. The role of the hypoxia-inducible factor in tumor metabolism growth and invasion.
Brahimi-Horn C; Pouysségur J
Bull Cancer; 2006 Aug; 93(8):E73-80. PubMed ID: 16935775
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-induced angiogenesis and tumor growth through the HIF-1-VEGF-dependent pathway in hyperglycemic nude mice.
Wang Y; Zhu YD; Gui Q; Wang XD; Zhu YX
Genet Mol Res; 2014 Sep; 13(3):7173-83. PubMed ID: 25222223
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia: a key regulator of angiogenesis in cancer.
Liao D; Johnson RS
Cancer Metastasis Rev; 2007 Jun; 26(2):281-90. PubMed ID: 17603752
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
Xia Y; Choi HK; Lee K
Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
[TBL] [Abstract][Full Text] [Related]
9. [Hypoxia in cancer malignity. Review].
Arvelo F; Cotte C
Invest Clin; 2009 Dec; 50(4):529-46. PubMed ID: 20306726
[TBL] [Abstract][Full Text] [Related]
10. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
11. Exploitation of the HIF axis for cancer therapy.
Escuin D; Simons JW; Giannakakou P
Cancer Biol Ther; 2004 Jul; 3(7):608-11. PubMed ID: 15197342
[TBL] [Abstract][Full Text] [Related]
12. Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies.
Mahdi A; Darvishi B; Majidzadeh-A K; Salehi M; Farahmand L
J Cell Physiol; 2019 May; 234(5):5655-5663. PubMed ID: 30515806
[TBL] [Abstract][Full Text] [Related]
13. The Sabotaging Role of Myeloid Cells in Anti-Angiogenic Therapy: Coordination of Angiogenesis and Immune Suppression by Hypoxia.
Li C; Liu T; Bazhin AV; Yang Y
J Cell Physiol; 2017 Sep; 232(9):2312-2322. PubMed ID: 27935039
[TBL] [Abstract][Full Text] [Related]
14. The ever-expanding role of HIF in tumour and stromal biology.
LaGory EL; Giaccia AJ
Nat Cell Biol; 2016 Apr; 18(4):356-65. PubMed ID: 27027486
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor in cancer angiogenesis: structure, regulation and clinical perspectives.
Otrock ZK; Hatoum HA; Awada AH; Ishak RS; Shamseddine AI
Crit Rev Oncol Hematol; 2009 May; 70(2):93-102. PubMed ID: 19186072
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia-inducible factor-1 and the down-regulation of VEGF gene expression.
Büchler P; Reber HA; Büchler MW; Friess H; Lavey RS; Hines OJ
Cancer; 2004 Jan; 100(1):201-10. PubMed ID: 14692041
[TBL] [Abstract][Full Text] [Related]
17. [The mechanism of tumor angiogenesis].
Ravaud A
Prog Urol; 2007 Feb; 17(1 Suppl 1):144-7. PubMed ID: 17571638
[No Abstract] [Full Text] [Related]
18. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer.
Boddy JL; Fox SB; Han C; Campo L; Turley H; Kanga S; Malone PR; Harris AL
Clin Cancer Res; 2005 Nov; 11(21):7658-63. PubMed ID: 16278385
[TBL] [Abstract][Full Text] [Related]
19. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
20. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.
Tang N; Wang L; Esko J; Giordano FJ; Huang Y; Gerber HP; Ferrara N; Johnson RS
Cancer Cell; 2004 Nov; 6(5):485-95. PubMed ID: 15542432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]